Glutatión sanguíneo en el paciente alcohólico con hepatopatía. Confirmación [carta]

Zentella de Piña, Martha; Díaz Belmont, Armando; Rodríguez Lizárraga, Lucelly; Rocha Hernández, Alma; Corona García, Sergio.
Rev. méd. Hosp. Gen. Méx ; 58(3): 136-7, jul.-sept. 1995.
Artículo en Español | LILACS | ID: lil-164577

Documentos relacionados

  1. Therapeutic Pipeline in Alcohol-Associated Liver Disease.
  2. Reply to: "Primed for the spotlight: Transplantation for alcohol-associated liver disease".
  3. Reply.
  4. Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: A narrative review.
  5. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
  6. Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease.
  7. [Essential phospholipids in the treatment of alcohol-related liver disease: clinical and experimental study].
  8. Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
  9. Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder.
  10. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease.